1. Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia;
2. Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
3. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia;
4. Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, VIC, Australia;
5. Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia;
6. Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
7. Victorian Cancer Cytogenetics Service, St. Vincent’s Hospital, Fitzroy, VIC, Australia;
8. Department of Medicine, St. Vincent’s Hospital, and
9. Department of Pathology, The University of Melbourne, Parkville, VIC, Australia;
10. School of Medical Sciences, University of Queensland, St. Lucia, QLD, Australia;
11. Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
12. Pimera Inc, San Diego, CA;
13. Clinical Haematology Unit, The Canberra Hospital, Canberra, ACT, Australia;
14. Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia;
15. Schools of Medicine and Biological Sciences, University of Adelaide, SA, Australia;
16. Research Institute of Molecular Pathology, Vienna, Austria;
17. Department of Clinical Haematology, The Alfred Hospital, Melbourne, VIC, Australia; and
18. Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia